Coave Therapeutics
Targeted gene therapies for rare diseases
- B2B
About Coave Therapeutics
Developing innovative gene therapies for rare ocular and CNS diseases using a unique platform for targeted delivery and enhanced effectiveness.
Key facts
- Industry
- Biotechnology Research
- Company size
- 51–250 employees
- Headquarters
- Paris, Île-de-France, France
- Founded
- 2014
- Revenue
- $7.9M – $62.2MTamtam estimate
- Website
- coavetx.com
- linkedin.com/company/coavetx
Coave Therapeutics at a glance
Coave Therapeutics is a B2B company in the Biotechnology Research industry, headquartered in Paris, Île-de-France, France.
Coave Therapeutics was founded in 2014.
Coave Therapeutics has 51–250 employees.
Coave Therapeutics's revenue is $7.9M – $62.2M (Tamtam estimate).
Frequently asked questions about Coave Therapeutics
What is Coave Therapeutics's revenue?
Tamtam estimates Coave Therapeutics's annual revenue at $7.9M – $62.2M.
How many employees does Coave Therapeutics have?
Coave Therapeutics has 51–250 employees.
Where is Coave Therapeutics headquartered?
Coave Therapeutics is headquartered in Paris, Île-de-France, France.
Selling to companies like Coave Therapeutics?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies